We are always available to take your enquiries. Please send an email or give us a call. For general press inquiries, please call +45 3643 3000.

Please note that the contacts listed to the right are for journalists or people with media related questions. If you are not a journalist, please visit the contact page and consult the appropriate Lundbeck contact.

About Lundbeck

We are a global pharmaceutical company highly committed to improving the quality of life for people suffering from brain diseases. For this purpose, we are engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. Our pharmaceuticals are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck is among the companies which have the largest research spend as a percentage of revenue. Every year Lundbeck invests around 20 percent of its revenue in the research and development of new innovative drugs, which will improve the treatment of the millions of people suffering from brain disorders all over the world. In total we employ around 1.300 highly qualified and specialised employees in our research and development departments.

In total Lundbeck, headquartered in Copenhagen, Denmark, employs approximately 5.800 people all over the world, 2.000 of which work in Denmark. Lundbeck has employees in 57 countries.